26 results  1 of 2 

1 Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
Hyungwoo Cho, Dok Hyun Yoon, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Seok Jin Kim, Young Rok Do, Gyeong-Won Lee, Jae-Yong Kwak, Yong Park, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Kwai Han Yoo, Won Sik Lee, Byeong Bae Park, Jae Cheol Jo, Hyeon-Seok Eom, Hyo Jung Kim, Seong Hyun Jeong, Young-Woong Won, Byeong Seok Sohn, Ji-Hyun Kwon, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.2023;55(2):684-692.   Published online 2023 January 2     DOI: http://dx.doi.org/10.4143/crt.2022.1434
      
2 Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
Kyoung Ha Kim, Jae Hoon Lee, Mark Lee, Hoon-Gu Kim, Young Rok Do, Yong Park, Sung Yong Oh, Ho-Jin Shin, Won Seog Kim, Seong Kyu Park, Jee Hyun Kong, Moo-Rim Park, Deok-Hwan Yang, Jae-Yong Kwak, Hye Jin Kang, Yeung-Chul Mun, Jong-Ho Won
Cancer Res Treat.2023;55(1):304-313.   Published online 2022 March 30     DOI: http://dx.doi.org/10.4143/crt.2022.004
      
3 Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
Aaron Wu, Solomon A. Graf, Nicholas Burwick, Jonathan E. Grim, Zhao Ming Dong, Robert E. Richard, Thomas R. Chauncey
Blood Res.2020;55(1):57-61.   Published online 2020 March 30     DOI: http://dx.doi.org/10.5045/br.2020.55.1.57
      
4 Recent advances in the management of primary central nervous system lymphoma
Yoon Seok Choi
Blood Res.2020;55(Supplement):S58-S62.   Published online 2019 July 30     DOI: http://dx.doi.org/10.5045/br.2020.S010
      
5 Recent advances in the management of primary central nervous system lymphoma
Yoon Seok Choi
Blood Res.2020;55(S1):S58-S62.   Published online 2019 July 30     DOI: http://dx.doi.org/10.5045/br.2020.S010
      
6 Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
Munira Shabbir-Moosajee, Samad Jehangir, Sobiya Sawani, Tariq Muhammed, Natasha Ali, Usman Sheikh, Salman Adil
Blood Res.2019;54(2):108-113.   Published online 2019 June 25     DOI: http://dx.doi.org/10.5045/br.2019.54.2.108
      
7 Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
Ja Min Byun, Jayoun Lee, Sang-Jin Shin, Minjoo Kang, Sung-Soo Yoon, Youngil Koh
Blood Res.2018;53(2):105-109.   Published online 2018 June 25     DOI: http://dx.doi.org/10.5045/br.2018.53.2.105
      
8 Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Children with Brain Tumors : Review of Single Center Experience
Ki Woong Sung, Do Hoon Lim, Hyung Jin Shin
J Korean Neurosurg Soc.2018;61(3):393-401.   Published online 2018 May 1     DOI: http://dx.doi.org/10.3340/jkns.2018.0039
      
9 Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents
Ji Won Lee, Do Hoon Lim, Ki Woong Sung, Hyeong Jin Lee, Eun Sang Yi, Keon Hee Yoo, Hong Hoe Koo, Yeon-Lim Suh, Hyung Jin Shin
J Korean Med Sci.2017;32(2):195-203.   Published online 2016 December 1     DOI: http://dx.doi.org/10.3346/jkms.2017.32.2.195
      
10 High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas
Young Bae Choi, Eun Sang Yi, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo
J Korean Med Sci.2016;31(7):1055-1062.   Published online 2016 May 16     DOI: http://dx.doi.org/10.3346/jkms.2016.31.7.1055
      
11 Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
Ki Woong Sung, Hee Won Chueh, Na Hee Lee, Dong Hwan Kim, Soo Hyun Lee, Keon Hee Yoo, Hong Hoe Koo, Eun Suk Kang, Dae Won Kim
J Korean Med Sci.2014;29(1):110-116.   Published online 2013 December 26     DOI: http://dx.doi.org/10.3346/jkms.2014.29.1.110
      
12 The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma
Chang-Ki Min, Sung-Eun Lee, Seung-Ah Yahng, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park
Blood Res.2013;48(3):198-205.   Published online 2013 September 25     DOI: http://dx.doi.org/10.5045/br.2013.48.3.198
      
13 Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma
Sung-Eun Lee, Jae-Ho Yoon, Seung-Hwan Shin, Gyeongsin Park, Chang-Ki Min
Immune Netw.2013;13(3):107-110.   Published online 2013 June 30     DOI: http://dx.doi.org/10.4110/in.2013.13.3.107
      
14 Hematologic Recovery after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk Solid Tumors
Meong Hi Son, Dong Hwan Kim, Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo, Ju Youn Kim, Eun Joo Cho, Eun Suk Kang, Dae Won Kim
J Korean Med Sci.2013;28(2):220-226.   Published online 2013 January 29     DOI: http://dx.doi.org/10.3346/jkms.2013.28.2.220
      
15 Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma
Jae-Cheol Jo, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Sang-Wook Lee, Jin-Sook Ryu, Cheolwon Suh
Korean J Hematol.2012;47(2):119-125.   Published online 2012 June 26     DOI: http://dx.doi.org/10.5045/kjh.2012.47.2.119
      
16 High-dose chemotherapy and autologous stem cell transplantation for pediatric brain tumors
Soo Hyun Lee, Ki Woong Sung
J Korean Med Assoc.2012;55(5):430-437.   Published online 2012 May 16     DOI: http://dx.doi.org/10.5124/jkma.2012.55.5.430
      
17 Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
Soo Jin Bae, Christine Kang, Ki Woong Sung, Hee Won Chueh, Meong Hi Son, Soo Hyun Lee, Keon Hee Yoo, Hong Hoe Koo
J Korean Med Sci.2012;27(4):363-369.   Published online 2012 March 21     DOI: http://dx.doi.org/10.3346/jkms.2012.27.4.363
      
18 Clinical Significance of Oligoclonal Bands in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation
Chang Eun Yoon, Young Jun Hong, Jin Kyung Lee, Seok-Il Hong, Hye Jin Kang, Yoon Hwan Chang
Lab Med Online.2012;2(1):28-33.   Published online 2012 January 1     DOI: http://dx.doi.org/10.3343/lmo.2012.2.1.5
      
19 Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor
Sun Young Kim, Ki Woong Sung, Jeong Ok Hah, Keon Hee Yoo, Hong Hoe Koo, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn, Ho Joon Im, Jong Jin Seo, Yeon Jung Lim, Young Ho Lee, Hyung Jin Shin, Do Hoon Lim, Byung Kyu Cho, Young Shin Ra, Joong Uhn Choi
Korean J Hematol.2010;45(2):120-126.   Published online 2010 June 30     DOI: http://dx.doi.org/10.5045/kjh.2010.45.2.120
      
20 Clinical Characteristics and Treatment Results of Pediatric Osteosarcoma: The Role of High Dose Chemotherapy with Autologous Stem Cell Transplantation
Ji Won Lee, Hyery Kim, Hyoung Jin Kang, Han-Soo Kim, Sung-Hye Park, In-One Kim, Hyo Seop Ahn, Hee Young Shin
Cancer Res Treat.2008;40(4):172-177.   Published online 2008 December 31     DOI: http://dx.doi.org/10.4143/crt.2008.40.4.172
      

 1 of 2